OnKure Therapeutics, Inc.
+74.4% · 90d
$4.97
+0.17 (+3.54%)
News
(1)April 2026
OnKure proposes increasing equity shares and electing directors at annual meeting
OKUROnKure Therapeutics, Inc.
# 📜 What This Document Is 📢 This document is a **Proxy Statement (DEF 14A)**. Think of it as a detailed instruction manual mailed to stockholders before a big vote. It explains *why* the company needs you to vote and *what* specific proposals you will be voting on. The filing is for OnKure Thera
Read summaryView on SEC EDGAR
Peers in Biotechnology
VRTX#1
Vertex Pharmaceuticals Incorporated
$113.64B+0.64%
REGN#2
Regeneron Pharmaceuticals, Inc.
$78.80B-0.99%
ARGX#3
argenx SE
$49.22B+1.97%
ALNY#4
Alnylam Pharmaceuticals, Inc.
$42.61B-1.82%
ONC#5
BeOne Medicines AG
$34.75B+0.39%
INSM#6
Insmed Incorporated
$34.45B-0.37%
RPRX#7
Royalty Pharma plc
$27.86B+0.84%
BNTX#8
BioNTech SE
$23.26B-0.11%
ROIV#9
Roivant Sciences Ltd.
$20.38B+1.10%
MRNA#10
Moderna, Inc.
$20.34B-1.57%